AI-generated summary
The authors report a crossover randomized trial of 30 patients, in which a 940-nm laser or a placebo was applied before maxillary canine anesthetic injections. Pain was rated with the VAS and SEM scales, and the authors report a significant reduction in pain perception with photobiomodulation, with no adverse effects reported.
- Participants
- 30
- Who or what was studied
- Adult dental patients receiving bilateral maxillary canine infiltration anesthesia
- Wavelengths
- 940 nm
- Limits stated in the abstract
- The abstract describes a single small crossover trial of 30 patients and does not report the size of the effect or the certainty of the findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 10 J/cm2
- Power
- 500 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Visual analogue scale, Placebo effect, Laser, Trial registration, Crossover study, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.